Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Forte Biosciences Inc. (FBRX)
NASDAQ:FBRX
Forte Biosciences (FBRX) Stock Price & Analysis
250 Followers
FBRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.38 - $1.03
Previous Close$0.51
Volume2.08K
Average Volume (3M)22.19K
Market Cap
$19.09M
Enterprise Value-$11.31M
Total Cash (Recent Filing)$30.40M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.81
Next Earnings
Aug 12, 2024EPS Estimate
-$0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.01
Shares Outstanding36,442,380
10 Day Avg. Volume16,551
30 Day Avg. Volume22,186
Standard Deviation1.47
R-Squared0.00050
Alpha0.17
Financial Highlights & Ratios
Price to Book (P/B)0.62
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.34
Forecast
1Y Price Target
$3.58Price Target Upside601.96% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Forte Biosciences News
Ownership Overview
21.49% Insiders
5.73% Mutual Funds
50.11% Other Institutional Investors
22.67% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
FBRX FAQ
What was Forte Biosciences Inc.’s price range in the past 12 months?
Forte Biosciences Inc. lowest stock price was $0.38 and its highest was $1.03 in the past 12 months.
What is Forte Biosciences Inc.’s market cap?
Currently, no data Available
When is Forte Biosciences Inc.’s upcoming earnings report date?
Forte Biosciences Inc.’s upcoming earnings report date is Aug 12, 2024 which is in 39 days.
How were Forte Biosciences Inc.’s earnings last quarter?
Forte Biosciences Inc. released its earnings results on May 13, 2024. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of -$0.14 by -$0.02.
Is Forte Biosciences Inc. overvalued?
According to Wall Street analysts Forte Biosciences Inc.’s price is currently Undervalued.
Does Forte Biosciences Inc. pay dividends?
Forte Biosciences Inc. does not currently pay dividends.
What is Forte Biosciences Inc.’s EPS estimate?
Forte Biosciences Inc.’s EPS estimate is -$0.16.
How many shares outstanding does Forte Biosciences Inc. have?
Forte Biosciences Inc. has 36,442,380 shares outstanding.
What happened to Forte Biosciences Inc.’s price movement after its last earnings report?
Forte Biosciences Inc. reported an EPS of -$0.16 in its last earnings report, missing expectations of -$0.14. Following the earnings report the stock price went down -4.225%.
Which hedge fund is a major shareholder of Forte Biosciences Inc.?
Among the largest hedge funds holding Forte Biosciences Inc.’s share is Perceptive Advisors LLC. It holds Forte Biosciences Inc.’s shares valued at 2M.
---
Forte Biosciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-50.77%
12-Months-Change
Fundamentals
Return on Equity
-104.30%
Trailing 12-Months
Asset Growth
-12.78%
Trailing 12-Months
Company Description
Forte Biosciences Inc.
Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer. It is in the business of discovery, development, and commercialization of products for the treatment of cancer. The company was founded by Thomas E. Darcy, Harry E. Gruber, Douglas J. Jolly, and Dennis N. Berman in August 2007 and is headquartered San Diego, CA.
---
FBRX Stock 12 Month Forecast
Average Price Target
$3.58
▲(601.96% Upside)
Technical Analysis
Best Analysts Covering FBRX
1 Year
1 Year Success Rate
3/10 ratings generated profit
1 Year Average Return
-22.70%
reiterated a buy rating 2 months ago
Copying Michael Higgins's trades and holding each position for 1 Year would result in 30.00% of your transactions generating a profit, with an average return of -22.70% per trade.
---